Skip to content
superstack
Draft entry. Written from the cited papers but not yet reviewed by a person. Check the references before relying on any claim.
Choline source· Cholinergic

Citicoline

also CDP-choline · Cytidine 5'-diphosphocholine · Cytidine diphosphate choline · Citicholine

Citicoline (CDP-choline) is an intermediate in the synthesis of phosphatidylcholine, the main phospholipid in cell membranes [1]. It is a prescription drug in some countries and a supplement in others. A meta-analysis found it improved cognitive status in mild cognitive impairment, Alzheimer's disease and post-stroke dementia, though the underlying studies were of poor quality [2].

One of the better-supported choline sources for cognitive decline, with a broad but mostly low-quality evidence base.

2D chemical structure of Citicoline
C14H26N4O11P2488.32 g/molCID 13804 ↗
Human RCTs5 papers · 1991–2023 · 4 journals · 4 in humans
  • meta-analysis
  • RCT
  • trial
  • observational
  • preclinical / case
  • review / patent / other
  • retracted
1991 · clinical trial · A multicentre trial to evaluate the efficacy and tolerability of alpha-glycerylphosphorylcholine versus cytosine diphosphocholine in patients with vascular dementia.2002 · review · Citicoline: neuroprotective mechanisms in cerebral ischemia.2014 · RCT · Improvements in concentration, working memory and sustained attention following consumption of a natural citicoline-caffeine beverage.2020 · meta-analysis · Application of Citicoline in Neurological Disorders: A Systematic Review.2023 · meta-analysis · Is Citicoline Effective in Preventing and Slowing Down Dementia?-A Systematic Review and a Meta-Analysis.
in its favour
  • + Supplies both choline and cytidine for membrane repair
  • + Positive signal across several dementia studies
  • + Well tolerated
watch for
  • − Trial quality is generally poor
  • − Stroke results have been inconsistent

Overview

Citicoline is research-backed mostly in older and neurologically impaired populations. A systematic review of 47 articles concluded it is useful for slowing dementia progression and improving prognosis after stroke, and that it enhances cognitive function in healthy people. The authors also judged its effect after brain trauma unclear [3].

In the nootropics community it is the most common choline source paired with racetams such as Piracetam.

Mechanism

Citicoline is the direct precursor in the body's route to phosphatidylcholine. The usual explanation for its effects is that it stimulates phosphatidylcholine synthesis in injured brain tissue, though the experimental evidence for that is limited [1]. Animal work on cerebral ischaemia points to a second action as well, slowing membrane breakdown by inhibiting phospholipases and preserving cardiolipin and sphingomyelin [1].

Once it has been metabolised it also supplies choline, the raw material for acetylcholine. That is why the nootropics community treats it as a "choline source".

Direct targetswhat the molecule itself binds or acts on
  • Phosphatidylcholine synthesis (Kennedy pathway)activates
    supplies substrate for membrane phospholipid synthesis [1]
    moderate
Downstreamconsequences of that action, not targets of their own
  • Phospholipase activationblocks
    may limit membrane breakdown after ischaemia (animal data) [1]
    weak
  • Acetylcholine synthesisactivates
    its choline can feed acetylcholine production
    unclear

Safety

risks and cautions, not medical advice

Citicoline is well tolerated in the clinical literature, and none of the reviews cited here report serious adverse effects. The main caveat is about evidence rather than harm. The meta-analysis supporting its use in dementia rated the overall study quality as poor [2].

Adverse effects
reported, not universal
  • Generally well tolerated in clinical use [3]
Cautions
who should think twice
  • Sold as a prescription medicine in some countries and a supplement in others, so product quality varies
Limits of the evidence
what has not been shown
  • The dementia meta-analysis rated overall study quality as poor [2]
  • Stroke trials have given inconsistent results [1]
  • Healthy-volunteer data often come from combination products, which cannot isolate citicoline's contribution [4]

Interactions

documented pairs only, not exhaustive
  • Alpha-GPC
    compatible
    Two choline sources with no adverse interaction documented; taking both mostly duplicates the same lever
  • Caffeine
    compatible
    Studied together in a beverage that improved sustained attention in healthy adults [4]

FAQ

Citicoline or alpha-GPC?
Both supply choline. Citicoline also supplies cytidine and has the larger dementia literature [2]. An old open-label trial in vascular dementia favoured alpha-GPC on most tests [5].

References

entry last reviewed 2026-09-18
  1. [1]
    Citicoline: neuroprotective mechanisms in cerebral ischemia.
    Adibhatla RM, Hatcher JF, Dempsey RJJ Neurochem 2002reviewPMID 11796739◌ unreviewed
  2. [2]
    Is Citicoline Effective in Preventing and Slowing Down Dementia?-A Systematic Review and a Meta-Analysis.
    Bonvicini M, Travaglini S, Lelli D et al.Nutrients 2023meta-analysis · humanPMID 36678257◌ unreviewed
  3. [3]
    Application of Citicoline in Neurological Disorders: A Systematic Review.
    Jasielski P, Piędel F, Piwek M et al.Nutrients 2020meta-analysis · humanPMID 33053828◌ unreviewed
  4. [4]
    Improvements in concentration, working memory and sustained attention following consumption of a natural citicoline-caffeine beverage.
    Bruce SE, Werner KB, Preston BF et al.Int J Food Sci Nutr 2014RCT · humanPMID 25046515◌ unreviewed
  5. [5]